182 related articles for article (PubMed ID: 24454917)
1. Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study.
McKinnon LR; Hughes SM; De Rosa SC; Martinson JA; Plants J; Brady KE; Gumbi PP; Adams DJ; Vojtech L; Galloway CG; Fialkow M; Lentz G; Gao D; Shu Z; Nyanga B; Izulla P; Kimani J; Kimwaki S; Bere A; Moodie Z; Landay AL; Passmore JA; Kaul R; Novak RM; McElrath MJ; Hladik F
PLoS One; 2014; 9(1):e85675. PubMed ID: 24454917
[TBL] [Abstract][Full Text] [Related]
2. Stability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tract.
Liebenberg LJ; Gamieldien H; Mkhize NN; Jaumdally SZ; Gumbi PP; Denny L; Passmore JA
J Immunol Methods; 2011 Mar; 367(1-2):47-55. PubMed ID: 21324321
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women.
Iyer SS; Sabula MJ; Mehta CC; Haddad LB; Brown NL; Amara RR; Ofotokun I; Sheth AN
PLoS One; 2017; 12(6):e0178193. PubMed ID: 28570576
[TBL] [Abstract][Full Text] [Related]
4. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
Cohen CR; Moscicki AB; Scott ME; Ma Y; Shiboski S; Bukusi E; Daud I; Rebbapragada A; Brown J; Kaul R
AIDS; 2010 Aug; 24(13):2069-74. PubMed ID: 20588163
[TBL] [Abstract][Full Text] [Related]
6. Optimization of processing female genital tissue samples for lymphocyte analysis by flow cytometry.
Stoner KA; Beamer MA; Avolia HA; Meyn LA; Hillier SL; Achilles SL
Am J Reprod Immunol; 2020 May; 83(5):e13227. PubMed ID: 31991032
[TBL] [Abstract][Full Text] [Related]
7. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells.
Masson L; Salkinder AL; Olivier AJ; McKinnon LR; Gamieldien H; Mlisana K; Scriba TJ; Lewis DA; Little F; Jaspan HB; Ronacher K; Denny L; Abdool Karim SS; Passmore JA
Immunology; 2015 Dec; 146(4):557-67. PubMed ID: 26302175
[TBL] [Abstract][Full Text] [Related]
8. Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women.
Bere A; Denny L; Hanekom W; Burgers WA; Passmore JA
J Immunol Methods; 2010 Mar; 354(1-2):68-79. PubMed ID: 20149794
[TBL] [Abstract][Full Text] [Related]
9. Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
Mauck CK; Lai JJ; Weiner DH; Chandra N; Fichorova RN; Dezzutti CS; Hillier SL; Archer DF; Creinin MD; Schwartz JL; Callahan MM; Doncel GF
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1475-86. PubMed ID: 23885658
[TBL] [Abstract][Full Text] [Related]
10. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
11. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
Nowicki MJ; Laskus T; Nikolopoulou G; Radkowski M; Wilkinson J; Du WB; Rakela J; Kovacs A
J Infect Dis; 2005 Nov; 192(9):1557-65. PubMed ID: 16206070
[TBL] [Abstract][Full Text] [Related]
12. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract.
Nkwanyana NN; Gumbi PP; Roberts L; Denny L; Hanekom W; Soares A; Allan B; Williamson AL; Coetzee D; Olivier AJ; Burgers WA; Passmore JA
Immunology; 2009 Sep; 128(1 Suppl):e746-57. PubMed ID: 19740336
[TBL] [Abstract][Full Text] [Related]
13. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
14. Early HIV-1 target cells in human vaginal and ectocervical mucosa.
Shen R; Richter HE; Smith PD
Am J Reprod Immunol; 2011 Mar; 65(3):261-7. PubMed ID: 21118402
[TBL] [Abstract][Full Text] [Related]
15. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
Achilles SL; Meyn LA; Mhlanga FG; Matubu AT; Stoner KA; Beamer MA; Chirenje ZM; Hillier SL
Am J Reprod Immunol; 2020 Sep; 84(3):e13287. PubMed ID: 32533883
[TBL] [Abstract][Full Text] [Related]
16. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.
Reichelderfer PS; Coombs RW; Wright DJ; Cohn J; Burns DN; Cu-Uvin S; Baron PA; Coheng MH; Landay AL; Beckner SK; Lewis SR; Kovacs AA
AIDS; 2000 Sep; 14(14):2101-7. PubMed ID: 11061650
[TBL] [Abstract][Full Text] [Related]
17. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.
Shannon B; Yi TJ; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Remis R; Rebbapragada A; Kaul R
J Immunol; 2014 Jun; 192(11):5074-82. PubMed ID: 24760150
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1.
Kovacs A; Chan LS; Chen ZC; Meyer WA; Muderspach L; Young M; Anastos K; Levine AM
J Acquir Immune Defic Syndr; 1999 Oct; 22(2):124-31. PubMed ID: 10843525
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of T cells from semen.
Olivier AJ; Liebenberg LJ; Coetzee D; Williamson AL; Passmore JA; Burgers WA
J Immunol Methods; 2012 Jan; 375(1-2):223-31. PubMed ID: 22094241
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.
Meditz AL; Palmer C; Predhomme J; Searls K; Kerr B; Seifert S; Caraway P; Gardner EM; MaWhinney S; Anderson PL
AIDS Res Hum Retroviruses; 2015 Oct; 31(10):1015-22. PubMed ID: 26059647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
